Literature DB >> 20061078

Brain MRI findings in long-standing and disabling multiple sclerosis in 84 patients.

Dimitri Renard1, Giovanni Castelnovo, Philippe-Jean Bousquet, Nicolas de Champfleur, Jérôme de Seze, Patrick Vermersch, Pierre Labauge.   

Abstract

OBJECTIVE: To look for cerebral white matter MRI changes in patients with long-standing and disabling MS.
METHODS: We analyzed retrospectively brain MRIs (performed 10 or more years after symptom onset) of patients with MS diagnosis and expanded disability status scale of 6 or more. The following parameters were analyzed: total number of brain T2 hyperintensities; number of brainstem, cerebellar, corpus callosum, basal ganglia, and juxtacortical T2 hyperintensities; diffuse leukoencephalopathy score; total number of T1 hypointensities.
RESULTS: Eighty-four patients were included. The mean time between symptom onset and MRI was 20.2 years. Eight percent had less than 9 cerebral T2 hyperintensities. Posterior fossa, juxtacortical, and corpus callosum T2 hyperintensities, and T1 hypointensities lacked in respectively 19%, 12%, 47%, and 8%. Overall, normal MRI was not seen, 6% had abnormal MRI but did not meet Barkhof's criteria, and the remaining 94% had MRI abnormalities fulfilling Barkhof's criteria. Moderate or severe diffuse leukoencephalopathy was seen in 69%. Extensive diffuse leukoencephalopathy predominant to nodular lesions was seen in 5%.
CONCLUSIONS: Despite long-standing and disabling MS, typical MRI abnormalities lacked in a minority of patients, and 6% did not fulfil Barkhof's criteria. The majority showed moderate or severe diffuse leukoencephalopathy. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20061078     DOI: 10.1016/j.clineuro.2009.12.012

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  7 in total

Review 1.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

Review 2.  Magnetic resonance imaging in neuromyelitis optica spectrum disorder.

Authors:  Laura Clarke; Simon Arnett; Kate Lilley; Jacky Liao; Sandeep Bhuta; Simon A Broadley
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 4.330

3.  Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.

Authors:  Zhengqi Lu; Bingjun Zhang; Wei Qiu; Zhuang Kang; Liping Shen; Youming Long; Junqi Huang; Xueqiang Hu
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

Review 4.  Magnetic Resonance Imaging as a Prognostic Disability Marker in Clinically Isolated Syndrome and Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Amjad I AlTokhis; Abrar AlAmrani; Abdulmajeed Alotaibi; Anna Podlasek; Cris S Constantinescu
Journal:  Diagnostics (Basel)       Date:  2022-01-21

5.  The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease.

Authors:  Ruth Geraldes; Maciej Juryńczyk; Giordani Rodrigues Dos Passos; Alexander Pichler; Karen Chung; Marloes Hagens; Serena Ruggieri; Cristina Auger; Jaume Sastre-Garriga; Christian Enzinger; Declan Chard; Frederik Barkhof; Claudio Gasperini; Alex Rovira; Gabriele DeLuca; Jacqueline Palace
Journal:  Mult Scler       Date:  2020-08-06       Impact factor: 6.312

Review 6.  Thalamic lesions: a radiological review.

Authors:  Dimitri Renard; Giovanni Castelnovo; Chantal Campello; Stephane Bouly; Anne Le Floch; Eric Thouvenot; Anne Waconge; Guillaume Taieb
Journal:  Behav Neurol       Date:  2014-07-02       Impact factor: 3.342

7.  Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?

Authors:  João J Cerqueira; D Alastair S Compston; Ruth Geraldes; Mario M Rosa; Klaus Schmierer; Alan Thompson; Michela Tinelli; Jacqueline Palace
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-04-04       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.